Sarcopenia in Patients with Chronic Liver Disease: Can It Be Altered by Diet and Exercise?

被引：33
作者：
Kappus M.R. [1 ]
Mendoza M.S. [2 ]
Nguyen D. [3 ]
Medici V. [4 ]
McClave S.A. [5 ]
机构：
[1] Department of Medicine, Duke University Medical Center, DUMS 03142, Orange Zone, Durham, 27710, NC
[2] Department of Medicine, Ochsner Clinic, New Orleans, LA
[3] Department of Medicine, College of Medicine, University of California—Irvine, Irvine, CA
[4] Department of Medicine, University of California-Davis, Davis, CA
[5] Department of Medicine, School of Medicine, University of Louisville, Louisville, KY
来源：
Current Gastroenterology Reports | 2016年 / 18卷 / 8期
关键词：
Cirrhosis; Liver disease; Malnutrition; Muscle wasting; Portal hypertension; Protein malnutrition; Sarcopenia;
D O I：
10.1007/s11894-016-0516-y
中图分类号：
学科分类号：
摘要：
Sarcopenia, a loss of muscle mass, is being increasingly recognized to have a deleterious effect on outcomes in patients with chronic liver disease. Factors related to diet and the inflammatory nature of chronic liver disease contribute to the occurrence of sarcopenia in these patients. Sarcopenia adversely influences quality of life, performance, morbidity, success of transplantation, and even mortality. Specific deficiencies in macronutrients (protein, polyunsaturated fatty acids) and micronutrients (vitamins C, D, and E, carotenoids, and selenium) have been linked to sarcopenia. Lessons learned from nutritional therapy in geriatric patient populations may provide strategies to manage sarcopenia in patients with liver disease. Combining diet modification and nutrient supplementation with an organized program of exercise may help ameliorate or even reverse the effects of sarcopenia on an already complex disease process. © 2016, Springer Science+Business Media New York.
引用
收藏
相关论文
共 73 条
  • [1] Wolfe R.A., McCullough K.P., Leichtman A.B., Predictability of survival models for waiting list and transplant patients: calculating LYFT, Am J Transplant, 9, 7, pp. 1523-1527, (2009)
  • [2] Schaubel D.E., Et al., Survival benefit-based deceased-donor liver allocation, Am J Transplant, 9, 4, pp. 970-981, (2009)
  • [3] Sharma P., Et al., Re-weighting the model for end-stage liver disease score components, Gastroenterology, 135, 5, pp. 1575-1581, (2008)
  • [4] Montano-Loza A.J., Et al., Severe muscle depletion predicts postoperative length of stay but is not associated with survival after liver transplantation, Liver Transpl, 20, 6, pp. 640-648, (2014)
  • [5] Cruz-Jentoft A.J., Et al., Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People, Age Ageing, 39, 4, pp. 412-423, (2010)
  • [6] von Haehling S., Morley J.E., Anker S.D., An overview of sarcopenia: facts and numbers on prevalence and clinical impact, J Cachexia Sarcopenia Muscle, 1, 2, pp. 129-133, (2010)
  • [7] Jancova-Vseteckova J., Et al., Social patterning in grip strength, chair rise, and walk speed in an aging population: the Czech HAPIEE Study, J Aging Phys Act, 23, 2, pp. 264-271, (2015)
  • [8] Syddall H., Et al., Social inequalities in grip strength, physical function, and falls among community dwelling older men and women: findings from the Hertfordshire Cohort Study, J Aging Health, 21, 6, pp. 913-939, (2009)
  • [9] Nieuwenhuizen W.F., Et al., Older adults and patients in need of nutritional support: review of current treatment options and factors influencing nutritional intake, Clin Nutr, 29, 2, pp. 160-169, (2010)
  • [10] Murphy C., The chemical senses and nutrition in older adults, J Nutr Elder, 27, 3-4, pp. 247-265, (2008)
12345678